Resources about ethical, legal, and social issues (ELSI) related to genetics and genomics in clinical practice
Accessing and using genetic information clinically can raise unique ethical, legal, and social concerns, generally known as ELSI. For example, unlike most other types of medical information, identifying a genetic variant in a patient may also diagnose his or her close relatives with the condition without them ever agreeing to testing. Recognizing what these issues may be in a specific situation provides the opportunity to discuss them directly with patients and identify ways to address them. The resources below discuss ELSI issues, their clinical implications, and ways to discuss them with patients.
GINA Discussion Guide. Provides talking points and key information about genetic discrimination and the Genetic Information Nondiscrimination Act (GINA), which protects individuals from the misuse of genetic information in health insurance and employment.
Communicating with Family Factsheet. Provides tips for the provider to assist in family communication about genetic testing and risk.
Informed Consent Checklist. Outlines key points to include in pretest counseling that help prepare an individual for the potential outcomes of genetic testing.
Core Competencies for Healthcare Providers. Identifies competencies in genetics for all healthcare providers, developed by the National Coalition for Health Professional Education in Genetics (NCHPEG).
Free, self-directed programs for continuing education credit. Courses contain case studies and/or information that discuss ELSI implications in clinical practice.
The traditional approach to genetic testing for those of Ashkenazi Jewish ancestry is under debate, with some experts calling for testing...
The Jackson Laboratory (JAX) has received $2.5 million from The Mark Foundation for Cancer Research to study in mice the influence of host...
Using a new meta-knowledgebase, cancer researchers have demonstrated improved matching between a patient cohort and variant interpretations...
JAX receives $6.1M, 5-year NIH grant for laboratory mouse resource program.
Computational scientists are on the front lines in the cancer fight.
PDX tumor models retain much of the biological diversity and heterogeneity of the original patient tumor. Advances in the development of...
Splicing factors, comparable to gene editors in our DNA, could hold the key to treating the worst type of breast cancer.
Family history resources for healthcare providers.
Core principles that should constitute basic instruction in genetics for those in health care.
GINA protects individuals from the misuse of genetic information in health insurance and employment. These case studies provide context for...
Resources for clinical educators teaching genetics.
The Jackson Laboratory Cancer Center (JAXCC) is a National Cancer Institute-designated Cancer Center complemented by institutional...
Genetic testing resources for healthcare providers.
GINA protects individuals from the misuse of genetic information in health insurance and employment. This overview provides information...
First global online catalog of Patient-Derived Xenograft models helps cancer researchers save valuable time.
The health and genetic quality of research mice significantly impact the quality of research data. Join this webinar to...
These cookies are required for basic site operations.
Allow Essential cookies
Analytics cookies are used to analyze web traffic to improve the user experience.
Allow Analytics cookies
Marketing cookies are used to enable social media features, personalize content and improve site interactivity.
Allow Marketing cookies